title: Functionally distinct pools of actin in secretory cells.
abstract: Acid secretion by the gastric parietal cell is controlled through movement of vesicles containing the proton pump, the H(+)-K(+)-ATPase (HK). We have used latrunculin B (Lat B), which binds to monomeric actin, to investigate actin turnover in the stimulated parietal cell. In isolated gastric glands, relatively high concentrations of Lat B were required to inhibit acid accumulation (ED(50) approximately 70 microM). Cultured parietal cells stimulated in the presence of low Lat B (0.1--1 microM) have reduced lamellipodia formation and some aberrant punctate phalloidin-stained structures, but translocation of HK and vacuolar swelling appeared unaffected. High Lat B (10--50 microM) resulted in gross changes in actin organization (punctate phalloidin-stained structures throughout the cell and nucleus) and reduced translocation of HK and vacuolar swelling. Resting parietal cells treated with high Lat B showed minor effects on morphology and F-actin staining. If resting cells treated with high Lat B were washed immediately before stimulation, they exhibited a normal stimulated morphology. These data suggest distinct pools of parietal cell actin: a pool highly susceptible to Lat B primarily involved in motile function of cultured cells; and a Lat B-resistant pool, most likely microvillar filaments, that is essential for secretion. Furthermore, the stimulation process appears to accentuate the effects of Lat B, most likely through Lat B binding to monomer actin liberated by the turnover of the motile actin filament pool.
authors.affiliation: Department of Molecular and Cell Biology, University of California, Berkeley, California 94720, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Ammar
authors.forename: P N
authors.initials: PN
authors.lastname: Nguyen
authors.forename: J G
authors.initials: JG
authors.lastname: Forte
mesh_terms: D000143:Acids / Q000037:antagonists & inhibitors; D000199:Actins / Q000378:metabolism*; D000818:Animals; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000494:pharmacology; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D005753:Gastric Mucosa / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D006706:Homeostasis; D066298:In Vitro Techniques; D010295:Parietal Cells, Gastric / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D011817:Rabbits; D013268:Stimulation, Chemical; D013844:Thiazoles / Q000494:pharmacology; D053778:Thiazolidines
chemical_list: D000143:Acids; D000199:Actins; D019086:Bridged Bicyclo Compounds, Heterocyclic; D013844:Thiazoles; D053778:Thiazolidines; C037068:latrunculin B; C037067:latrunculin A